Hematopoietic cell transplantation in non-Hodgkin's lymphoma.
OBJECTIVE
To explore the role and outcomes using hematopoietic cell transplantation (HCT) as a treatment option with aggressive, follicular, mantle, T-cell, and HIV related non-Hodgkin's lymphoma (NHL).


METHODS
Research and review articles and textbooks.


CONCLUSIONS
High-dose chemotherapy and/or radiation therapy followed by HCT has been used to overcome resistance to standard-dose therapy and has been explored over the past 40 years and has shown long-term survival of approximately 10% to 50% in patients with relapsed or refractory lymphoma.


CONCLUSIONS
Nursing plays a significant role in the assessment and management of patients throughout the course of HCT.
Steingass
Sharon K
SK
Department of Clinical Practice and Professional Education, City of Hope National Medical Center, Duarte, CA 91010, USA. ssteingass@coh.org
D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000451:nursing; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000451:nursing / Q000628:therapy; D008224:Lymphoma, Follicular / Q000451:nursing / Q000628:therapy; D020522:Lymphoma, Mantle-Cell / Q000451:nursing / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000451:nursing / Q000628:therapy*; D016399:Lymphoma, T-Cell / Q000451:nursing / Q000628:therapy; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000451:nursing